Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from SAWAI GROUP HOLDINGS Co., Ltd. ( (JP:4887) ) is now available.
Sawai Group Holdings reported a 12.5% increase in revenue for the six months ending September 30, 2025, despite a significant decline in profits due to the classification of its U.S. business as a discontinued operation. The company anticipates a strong recovery in profits for the fiscal year ending March 31, 2026, with expected operating profit and profit before tax showing substantial year-on-year growth.
The most recent analyst rating on (JP:4887) stock is a Hold with a Yen1980.00 price target. To see the full list of analyst forecasts on SAWAI GROUP HOLDINGS Co., Ltd. stock, see the JP:4887 Stock Forecast page.
More about SAWAI GROUP HOLDINGS Co., Ltd.
Sawai Group Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. It focuses on the development, production, and distribution of generic drugs, aiming to provide affordable medication options to the market.
Average Trading Volume: 365,104
Technical Sentiment Signal: Sell
Current Market Cap: Yen184.9B
See more insights into 4887 stock on TipRanks’ Stock Analysis page.